Sofinnova Investments, Inc. Immuno Gen, Inc. Call Options Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 11, 2023	BUY	$3.67 - $4.92 $3.67 Million - $4.92 Million	1,000,000 New	1,000,000 $3.84 Million
Q2 2019 Aug 13, 2019	SELL	$1.8 - $3.3 $270,000 - $495,000	-150,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $361,500 - $886,500	150,000 New	150,000 $406,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.